Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...

Traders are becoming worried about market froth and overvaluation for stocks as they digest headlines about tariffs and peak corporate profit margins. Two out of three traders believe the stock market ...

Reports Q4 revenue $33.8M, consensus $33.73M. “Record Q4 sales bookings capped a strong year, validating early traction in our Go-To-Market ...

A federal judge’s decision on an Ontario nuclear waste facility has set a new precedent for what consultation with First Nations should look like, raising the standard for projects across ...

Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...

While decades of advocacy have pushed for the inclusion of women in clinical trials, a new study funded by Women’s Health ...

1. Prioritize: Not everything holds equal importance, and that's okay. So you must first identify the moments—both in work ...

Health data is often not interoperable. Fraunhofer IESE and others want to change this and are developing a large language ...

We’ve become desensitized to large sums of money. Billions feel ordinary. This detachment influences wealth inequality and ...

Humm is a turnaround story, and we expect it will ultimately maintain its footing in the highly competitive financing market. Humm was wrong-footed by its nimbler, customer-centric BNPL peers in the ...

The Tory leader will also advocate a ‘need to disengage’ from international bodies if they are ‘taken over by activists or by ...